Cargando…

Molecular Biomarkers Predictive of Sertraline Treatment Response in Young Children With Autism Spectrum Disorder

Sertraline is one among several selective serotonin reuptake inhibitors (SSRIs) that exhibited improvement of language development in Autism Spectrum Disorder (ASD); however, the molecular mechanism has not been elucidated. A double blind, randomized, 6-month, placebo-controlled, clinical trial of l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alolaby, Reem Rafik, Jiraanont, Poonnada, Durbin-Johnson, Blythe, Jasoliya, Mittal, Tang, Hiu-Tung, Hagerman, Randi, Tassone, Flora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174723/ https://www.ncbi.nlm.nih.gov/pubmed/32346385 http://dx.doi.org/10.3389/fgene.2020.00308

Ejemplares similares

Profiling Genome-Wide DNA Methylation in Children with Autism Spectrum Disorder and in Children with Fragile X Syndrome
por: Jasoliya, Mittal, et al.
Publicado: (2022)

Clinical and molecular correlates in fragile X premutation females
por: Jiraanont, Poonnada, et al.
Publicado: (2017)

A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder
por: Potter, Laura A., et al.
Publicado: (2019)

Blood-Based Biomarkers Predictive of Metformin Target Engagement in Fragile X Syndrome
por: Jasoliya, Mittal, et al.
Publicado: (2020)

De Novo Large Deletion Leading to Fragile X Syndrome
por: Jiraanont, Poonnada, et al.
Publicado: (2022)

Assessment of Molecular Measures in Non-FXTAS Male Premutation Carriers
por: Al Olaby, Reem R., et al.
Publicado: (2018)

Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins
por: Napoli, Eleonora, et al.
Publicado: (2018)

Clinical and molecular implications of mosaicism in FMR1 full mutations
por: Pretto, Dalyir, et al.
Publicado: (2014)

FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability
por: Roth, Mark, et al.
Publicado: (2021)

Prenatal Diagnosis of Fragile X: Can a Full Mutation Allele in the FMR1 Gene Contract to a Normal Size?
por: Manor, Esther, et al.
Publicado: (2017)

Clinical implications of somatic allele expansion in female FMR1 premutation carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2023)

Urine-Derived Epithelial Cell Lines: A New Tool to Model Fragile X Syndrome (FXS)
por: Zafarullah, Marwa, et al.
Publicado: (2020)

Review of Autism Profiles and Response to Sertraline in Fragile X Syndrome-Associated Autism vs. Non-syndromic Autism; Next Steps for Targeted Treatment
por: Rajaratnam, Akash, et al.
Publicado: (2020)

FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS)
por: Zafarullah, Marwa, et al.
Publicado: (2020)

Blood Proteome Profiling Reveals Biomarkers and Pathway Alterations in Fragile X PM at Risk for Developing FXTAS
por: Zafarullah, Marwa, et al.
Publicado: (2023)

Activation Ratio Correlates with IQ in Female Carriers of the FMR1 Premutation
por: Protic, Dragana, et al.
Publicado: (2023)

The Role of AGG Interruptions in the Transcription of FMR1 Premutation Alleles
por: Yrigollen, Carolyn M., et al.
Publicado: (2011)

Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014)

An Update on Psychopharmacological Treatment of Autism Spectrum Disorder
por: Aishworiya, Ramkumar, et al.
Publicado: (2022)

The Gut Microbiota and Autism Spectrum Disorders
por: Li, Qinrui, et al.
Publicado: (2017)

Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2022)

Sertraline May Improve Language Developmental Trajectory in Young Children with Fragile X Syndrome: A Retrospective Chart Review
por: Indah Winarni, Tri, et al.
Publicado: (2012)

Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism
por: Wang, Xiao-Hong, et al.
Publicado: (2018)

Serotonin Syndrome with Monotherapy of Low-Dose Sertraline in an Adult Patient with Autism Spectrum Disorder
por: Madan, Rohit, et al.
Publicado: (2023)

Fragile X-Associated Tremor/Ataxia Syndrome: Unmet Needs and a Path for the Future
por: Hall, Deborah A., et al.
Publicado: (2018)

Channelopathy pathogenesis in autism spectrum disorders
por: Schmunk, Galina, et al.
Publicado: (2013)

Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer’s Disease
por: Aydin, Elber Yuksel, et al.
Publicado: (2020)

Fragile X Syndrome
por: McLennan, Yingratana, et al.
Publicado: (2011)

Predicting the Risk Genes of Autism Spectrum Disorders
por: Lin, Yenching, et al.
Publicado: (2021)

Brain Metabolomics in Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS)
por: Salcedo-Arellano, Maria Jimena, et al.
Publicado: (2023)

Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers
por: Giulivi, Cecilia, et al.
Publicado: (2016)

The Evolving Diagnostic and Genetic Landscapes of Autism Spectrum Disorder
por: Ziats, Mark N., et al.
Publicado: (2016)

Metabolomic Biomarkers Are Associated With Area of the Pons in Fragile X Premutation Carriers at Risk for Developing FXTAS
por: Zafarullah, Marwa, et al.
Publicado: (2021)

Fragile X and autism: Intertwined at the molecular level leading to targeted treatments
por: Hagerman, Randi, et al.
Publicado: (2010)

FMR1 premutation and full mutation molecular mechanisms related to autism
por: Hagerman, Randi, et al.
Publicado: (2011)

New insights into the genetic mechanism of IQ in autism spectrum disorders
por: Wang, Harold Z., et al.
Publicado: (2013)

Dissecting the multifaceted contribution of the mitochondrial genome to autism spectrum disorder
por: Caporali, Leonardo, et al.
Publicado: (2022)

Association of the Lactase Persistence Haplotype Block With Disease Risk in Populations of European Descent
por: Joslin, Shannon E. K., et al.
Publicado: (2020)

Differential Methylation Profile in Fragile X Syndrome-Prone Offspring Mice after in Utero Exposure to Lactobacillus Reuteri
por: AlOlaby, Reem R., et al.
Publicado: (2022)

Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X Syndrome
por: Stöger, Reinhard, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l874ni8invaaj2g44pfl9a7otp